(VIANEWS) – Cameco Corporation (CCJ), Palomar Holdings (PLMR), Embraer S.A. (ERJ) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Cameco Corporation (CCJ)
25.9% sales growth and 4.23% return on equity
Cameco Corporation produces and sells uranium. It operates in two segments, Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services. This segment also produces fuel bundles or reactor components for CANDU reactors. The company sells its uranium and fuel services to nuclear utilities in the Americas, Europe, and Asia. Cameco Corporation was incorporated in 1987 and is headquartered in Saskatoon, Canada.
Earnings Per Share
As for profitability, Cameco Corporation has a trailing twelve months EPS of $0.43.
PE Ratio
Cameco Corporation has a trailing twelve months price to earnings ratio of 99.09. Meaning, the purchaser of the share is investing $99.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.23%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 29, 2023, the estimated forward annual dividend rate is 0.09 and the estimated forward annual dividend yield is 0.21%.
2. Palomar Holdings (PLMR)
21.9% sales growth and 20.38% return on equity
Palomar Holdings, Inc., an insurance holding company, provides specialty property insurance to residential and commercial customers. The company offers personal and commercial specialty property insurance products, including residential and commercial earthquake, commercial all risk, specialty homeowners, inland marine, Hawaii hurricane, and residential flood, as well as other products, such as assumed reinsurance, commercial flood, real estate error and omission, and real estate investor products. It markets and distributes its products through retail agents, wholesale brokers, program administrators, and carrier partnerships. The company was formerly known as GC Palomar Holdings. Palomar Holdings, Inc. was incorporated in 2013 and is headquartered in La Jolla, California.
Earnings Per Share
As for profitability, Palomar Holdings has a trailing twelve months EPS of $3.8.
PE Ratio
Palomar Holdings has a trailing twelve months price to earnings ratio of 24.82. Meaning, the purchaser of the share is investing $24.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.38%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 13% and 23.4%, respectively.
Yearly Top and Bottom Value
Palomar Holdings’s stock is valued at $94.32 at 06:22 EST, under its 52-week high of $96.44 and way above its 52-week low of $48.08.
3. Embraer S.A. (ERJ)
17.6% sales growth and 13.03% return on equity
Embraer S.A. designs, develops, manufactures, and sells aircrafts and systems in Brazil, North America, Latin America, the Asia Pacific, Brazil, Europe, and internationally. It operates through Commercial Aviation; Defense and Security; Executive Jets; Service & Support; and Other segments. The Commercial Aviation segment designs, develops, and manufactures a variety of commercial aircrafts. The Defense and Security segment engages in the research, development, production, modification, and support for military defense and security aircraft; and offers a range of products and integrated solutions that include radars and special space systems, as well as information and communications systems comprising command, control, communications, computer, intelligence, surveillance, and reconnaissance systems. The Executive Jets segment develops, produces, and sells executive jets. It also leases Legacy 600 and Legacy 650 executive jets in the super midsize and large categories; Legacy 450 and Legacy 500 executive jets in the midlight and midsize categories; Phenom family executive jets in the entry jet and light jet categories; Lineage 1000, an ultra-large executive jet; and Praetor 500 and Praetor 600, disruptive executive jets in the midsize and super midsize categories. The Service & Support segment offers after-service solutions, support, and maintenance, repair, and overhaul services for commercial, executive, and defense aircrafts; provides aircraft components and engines; and supplies steel and composite aviation structures to various aircraft manufacturers. The Other segment is involved in the supply of fuel systems, structural parts, and mechanical and hydraulic systems; and production of agricultural crop-spraying aircraft. The company was formerly known as Embraer-Empresa Brasileira de Aeronáutica S.A. and changed its name to Embraer S.A. in November 2010. Embraer S.A. was incorporated in 1969 and is headquartered in São Paulo, Brazil.
Earnings Per Share
As for profitability, Embraer S.A. has a trailing twelve months EPS of $2.06.
PE Ratio
Embraer S.A. has a trailing twelve months price to earnings ratio of 16.35. Meaning, the purchaser of the share is investing $16.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.03%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.4%, now sitting on 28.32B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 105.6% and 81%, respectively.
4. LeMaitre Vascular (LMAT)
13.5% sales growth and 12.49% return on equity
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers restoreflow allografts; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access in patients with or without a previously-failed synthetic graft; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Earnings Per Share
As for profitability, LeMaitre Vascular has a trailing twelve months EPS of $1.67.
PE Ratio
LeMaitre Vascular has a trailing twelve months price to earnings ratio of 54.07. Meaning, the purchaser of the share is investing $54.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.49%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 15, 2024, the estimated forward annual dividend rate is 0.64 and the estimated forward annual dividend yield is 0.71%.
Previous days news about LeMaitre Vascular(LMAT)
- According to Zacks on Monday, 2 September, "While HCA Healthcare currently sports a Zacks Rank #1 (Strong Buy), The Ensign Group and LeMaitre Vascular carry a Zacks Rank #2 (Buy) each. "
5. The Ensign Group (ENSG)
12.4% sales growth and 14.78% return on equity
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. Its Standard Bearer segment is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. In addition, the company provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. It operates in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Earnings Per Share
As for profitability, The Ensign Group has a trailing twelve months EPS of $3.89.
PE Ratio
The Ensign Group has a trailing twelve months price to earnings ratio of 38.91. Meaning, the purchaser of the share is investing $38.91 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.78%.
Volume
Today’s last reported volume for The Ensign Group is 269498 which is 23.47% below its average volume of 352190.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 13.3% and 13.3%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.5%, now sitting on 3.97B for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 28, 2024, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 0.16%.
Previous days news about The Ensign Group(ENSG)
- According to Zacks on Monday, 2 September, "While HCA Healthcare currently sports a Zacks Rank #1 (Strong Buy), The Ensign Group and LeMaitre Vascular carry a Zacks Rank #2 (Buy) each. "
6. Tetra Tech (TTEK)
10.7% sales growth and 18.66% return on equity
Tetra Tech, Inc. provides consulting and engineering services worldwide. The company operates through Government Services Group (GSG) and Commercial/International Services Group (CIG) segments. The GSG segment offers early data collection and monitoring, data analysis and information technology, science and engineering applied research, engineering design, construction management, and operations and maintenance services; and climate change and energy management consulting, as well as greenhouse gas inventory assessment, certification, reduction, and management services. This segment serves federal, state, and local governments, and development agencies in water resources analysis and water management, environmental monitoring, data analytics, government consulting, waste management, and a range of civil infrastructure master planning and engineering design markets. The CIG segment provides early data collection and monitoring, data analysis and information management, feasibility studies and assessments, science and engineering applied research, engineering design, construction management, and operations and maintenance services. This segment serves natural resources, energy, and utilities markets, as well as civil infrastructure master planning and engineering design markets. Tetra Tech, Inc. was founded in 1966 and is headquartered in Pasadena, California.
Earnings Per Share
As for profitability, Tetra Tech has a trailing twelve months EPS of $5.4.
PE Ratio
Tetra Tech has a trailing twelve months price to earnings ratio of 43.17. Meaning, the purchaser of the share is investing $43.17 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.66%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.4%, now sitting on 4.23B for the twelve trailing months.
Sales Growth
Tetra Tech’s sales growth is 7.2% for the current quarter and 10.7% for the next.
7. Barrett Business Services (BBSI)
6.1% sales growth and 26.18% return on equity
Barrett Business Services, Inc. provides business management solutions for small and mid-sized companies in the United States. The company develops a management platform that integrates a knowledge-based approach from the management consulting industry with tools from the human resource outsourcing industry. It offers professional employer services under which it enters into a client services agreement to establish a co-employment relationship with each client company, assuming responsibility for payroll, payroll taxes, workers' compensation coverage, and other administration functions for the client's existing workforce. The company also provides staffing and recruiting services, such as on-demand or short-term staffing assignment, contract staffing, direct placement, and long-term or indefinite-term on-site management services. It serves electronics manufacturers, light-manufacturing industries, agriculture-based companies, transportation and shipping enterprises, food processors, telecommunications companies, public utilities, general contractors in various construction-related fields, and professional services firms. The company was incorporated in 1965 and is headquartered in Vancouver, Washington.
Earnings Per Share
As for profitability, Barrett Business Services has a trailing twelve months EPS of $1.83.
PE Ratio
Barrett Business Services has a trailing twelve months price to earnings ratio of 19.77. Meaning, the purchaser of the share is investing $19.77 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.18%.
Moving Average
Barrett Business Services’s value is higher than its 50-day moving average of $34.48 and way higher than its 200-day moving average of $30.88.
Volume
Today’s last reported volume for Barrett Business Services is 79667 which is 54.77% below its average volume of 176141.
Sales Growth
Barrett Business Services’s sales growth is 1.1% for the current quarter and 6.1% for the next.
Yearly Top and Bottom Value
Barrett Business Services’s stock is valued at $36.17 at 06:22 EST, below its 52-week high of $37.00 and way above its 52-week low of $21.59.
Previous days news about Barrett Business Services(BBSI)
- According to Zacks on Tuesday, 3 September, "Some better-ranked stocks in the broader Zacks Business Services sector are AppLovin (APP Quick QuoteAPP – Free Report) and Barrett Business Services (BBSI Quick QuoteBBSI – Free Report) ."
8. STAAR Surgical Company (STAA)
5.4% sales growth and 4.36% return on equity
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Earnings Per Share
As for profitability, STAAR Surgical Company has a trailing twelve months EPS of $0.33.
PE Ratio
STAAR Surgical Company has a trailing twelve months price to earnings ratio of 97.94. Meaning, the purchaser of the share is investing $97.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.36%.
